US · CHCT · REIT - HEALTHCARE FACILITIES
Community Healthcare Trust Incorporated (CHCT) intrinsic value and stock valuation
$14.24as of 2026-11-21 · Mkt cap 439.72M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Community Healthcare Trust Incorporated DCF and intrinsic value
InvestorsCraft values CHCT with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from CHCT’s statements →
Community Healthcare Trust Incorporated Graham Number
Graham Number: $8.27d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2014–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- National Healthcare Properties, Inc. (NHPBP) $25.44
- Universal Health Realty Income Trust (UHT) $37.22
- One Liberty Properties, Inc. (OLP) $20.64
- Farmland Partners Inc. (FPI) $9.29
- Five Point Holdings, LLC (FPH) $4.35
- NexPoint Real Estate Finance, Inc. (NREF) $11.26
- Claros Mortgage Trust, Inc. (CMTG) $1.41
- Net Lease Office Properties (NLOP) $6.84
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $121.2M | $115.8M | $112.8M | $97.7M | $90.6M |
| Operating income | $20.3M | $20.1M | $25.1M | $33.9M | $32.9M |
| Net income | $5.1M | -$-3.18M | $7.71M | $22M | $22.5M |
| EPSd | $189.9K | -$-119.86K | $306K | $931.9K | $966.9K |
| Operating cash flow | $56.4M | $58.9M | $61.4M | $60.3M | $56.4M |
| Capital expenditure | -$-20.52M | -$-24.64M | -$-18.98M | -$-10.38M | -$-7.22M |
| Free cash flow | $35.9M | $34.2M | $42.4M | $49.9M | $49.1M |
| Total assets | $990.8M | $992.6M | $945.4M | $876.4M | $754.2M |
| Total debt | $536.2M | $490M | $412.3M | $357.1M | $269.4M |
| Net debt | $532.9M | $485.6M | $408.8M | $345.8M | $267M |
| Total equity | $429.4M | $476M | $513.3M | $496.8M | $462.1M |
| Cash and short-term investments | $3.34M | $4.38M | $3.49M | $11.2M | $2.35M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $121.2M | $115.8M | $112.8M | $97.7M | $90.6M |
| Cost of revenue | $110.7M | $22.8M | $20.7M | $16.6M | $15.2M |
| Gross profit | $10.5M | $93M | $92.1M | $81M | $75.4M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $25.1M | $19.1M | $27.3M | $14.8M | $12.1M |
| Other expenses | -$-34.87M | $53.8M | $39.7M | $32.3M | $30.4M |
| Operating expenses | -$-9.77M | $72.8M | $67M | $47.2M | $42.5M |
| Cost and expenses | $100.9M | $95.7M | $87.7M | $63.8M | $57.7M |
| Interest income | -$-160K | $530K | $810K | $70K | $60K |
| Interest expense | $34.1M | $23.7M | $17.8M | $11.9M | $10.5M |
| Depreciation and amortization | $43.5M | $43.7M | $40.4M | $33.2M | $31.2M |
| Ebitda | $82.7M | $64.2M | $66.3M | $67.1M | $64.4M |
| Operating income | $20.3M | $20.1M | $25.1M | $33.9M | $32.9M |
| Total other income/expenses, net | -$-15.14M | -$-23.3M | -$-17.08M | -$-11.81M | -$-10.25M |
| Income before tax | $5.12M | -$-3.18M | $8.02M | $22.1M | $22.7M |
| Income tax expense | $20K | $0.00 | $310K | $40K | $170K |
| Net income | $5.1M | -$-3.18M | $7.71M | $22M | $22.5M |
| Weighted average shares outstanding | $26.9M | $26.5M | $25.2M | $23.6M | $23.3M |
| Weighted average diluted shares outstanding | $26.9M | $26.5M | $25.2M | $23.6M | $23.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $3.34M | $4.38M | $3.49M | $11.2M | $2.35M |
| Net receivables | $37.3M | $45.3M | $56.9M | $53.9M | $43.1M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $47.5M | $58.1M | $70.2M | $66.9M | $46.7M |
| Property, plant and equipment, net | $3.04M | $3.12M | $852.7M | $3.3M | $2.66M |
| Goodwill and intangible assets | $1.31M | $1.93M | $2.65M | $2.4M | $610K |
| Long-term investments | $0.00 | $0.00 | $16.4M | $0.00 | $0.00 |
| Total non-current assets | $943.3M | $934.5M | $856.5M | $809.5M | $707.6M |
| Total assets | $990.8M | $992.6M | $945.4M | $876.4M | $754.2M |
| Accounts payable | $0.00 | $0.00 | $12M | $0.00 | $0.00 |
| Short-term debt | $258M | $212M | $5.17M | $140K | $12M |
| Deferred revenue | $6.03M | $6.5M | $5.38M | $3.85M | $3.79M |
| Total current liabilities | $279M | $232.8M | $12.2M | $15.2M | $23.6M |
| Long-term debt | $278.2M | $278M | $407.1M | $357.1M | $257.4M |
| Deferred revenue, non-current | $0.00 | $0.00 | $5.38M | $0.00 | $3.79M |
| Total non-current liabilities | $282.4M | $283.8M | $419.9M | $364.4M | $268.5M |
| Capital lease obligations | $4M | $4.03M | $4.05M | $4.07M | $3.77M |
| Total liabilities | $561.4M | $516.6M | $432.2M | $379.6M | $292.1M |
| Common stock | $280K | $280K | $280K | $260K | $250K |
| Retained earnings | $90.8M | $85.7M | -$-191.59M | $81.1M | $59.1M |
| Accumulated other comprehensive income (loss) | -$-379.12M | -$-314.52M | -$-175.18M | -$-209.72M | -$-192.88M |
| Total equity | $429.4M | $476M | $513.3M | $496.8M | $462.1M |
| Total investments | $0.00 | $0.00 | $16.4M | $0.00 | $0.00 |
| Total debt | $536.2M | $490M | $412.3M | $357.1M | $269.4M |
| Net debt | $532.9M | $485.6M | $408.8M | $345.8M | $267M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $5.1M | -$-3.18M | $7.71M | $22M | $22.5M |
| Depreciation and amortization | $43.5M | $42.8M | $40.4M | $33.2M | $31.2M |
| Stock-based compensation | $10.3M | $9.99M | $20M | $9.41M | $7.16M |
| Change in working capital | -$-390K | -$-810K | -$-3.38M | -$-940K | -$-890K |
| Accounts receivable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $0.00 | $2.27M | $860K | $1.42M | -$-440K |
| Net cash provided by operating activities | $56.4M | $58.9M | $61.4M | $60.3M | $56.4M |
| Investments in property, plant and equipment | -$-20.52M | -$-24.64M | $0.00 | -$-10.38M | -$-7.22M |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $103.4M | $97.2M |
| Net cash used for investing activities | -$-47.7M | -$-92.66M | -$-113.67M | -$-113.77M | -$-104.43M |
| Common stock issued | $0.00 | $7.49M | $44.2M | $20.5M | $38.4M |
| Common stock repurchased | -$-1.79M | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | -$-53.67M | -$-51.7M | -$-48.06M | -$-44.48M | -$-42.41M |
| Net cash used for financing activities | -$-9.78M | $33.5M | $44.9M | $62.7M | $48.1M |
| Net change in cash | -$-1.04M | -$-250K | -$-7.43M | $9.2M | -$-30K |
| Cash at end of period | $3.34M | $4.38M | $4.63M | $12.1M | $2.87M |
| Operating cash flow | $56.4M | $58.9M | $61.4M | $60.3M | $56.4M |
| Capital expenditure | -$-20.52M | -$-24.64M | -$-18.98M | -$-10.38M | -$-7.22M |
| Free cash flow | $35.9M | $34.2M | $42.4M | $49.9M | $49.1M |
Line items
Line items
Line items
About Community Healthcare Trust Incorporated
Community Healthcare Trust Incorporated is a real estate investment trust. It focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of December 31, 2025, the Company had investments of approximately 1.2 billion US dollars in 198 real estate properties (including one property with sales-type leases and one property classified as held for sale). The properties are in 36 states, totaling approximately 4.5 million square feet in the aggregate. Community Healthcare Trust Incorporated was incorporated in 2014 in Maryland, USA.
- CEO
- David H. Dupuy
- Employees
- 35
- Beta
- 0.68
Included in
Explore
Frequently asked questions
What is the intrinsic value of Community Healthcare Trust Incorporated (CHCT)?
Community Healthcare Trust Incorporated (CHCT) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is CHCT undervalued?
CHCT trades at a price of $14.24 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.